Laura Sepp-Lorenzino, EVP, Chief Scientific Officer: Intellia Therapeutics NTLA Sell · Filed 24/01/10

Trade details

Type: Insider sale
Amount: $19,596.46
Shares · price: 667 sh · $29.38 a share
Held after: 43,927 sh
Stock: Intellia Therapeutics NTLA
Person: Laura Sepp-LorenzinoEVP, Chief Scientific Officer
Trade date: 24/01/08
Filed: 24/01/10
Days to filing: 2 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/09~24/02/07

Laura Sepp-Lorenzino's recent trades

Laura Sepp-LorenzinoEVP, Chief Scientific Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$109.2K
8,966 sh
$109.2K
Filed 25/01/07
Traded 25/01/03
Laura Sepp-LorenzinoEVP, Chief Scientific Officer
Sell10b5-1 planIntellia Therapeutics
Sell10b5-1 plan
Intellia Therapeutics
NTLA
$46.1K
1,608 sh
$46.1K
Filed 24/01/10
Traded 24/01/08
Laura Sepp-LorenzinoEVP, Chief Scientific Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$163K
5,532 sh
$163K
Filed 24/01/05
Traded 24/01/03
Laura Sepp-LorenzinoEVP, Chief Scientific Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$93.3K
2,508 sh
$93.3K
Filed 23/01/06
Traded 23/01/04
Laura Sepp-LorenzinoEVP, Chief Scientific Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$62.7K
1,641 sh
$62.7K
Filed 23/01/06
Traded 23/01/05

Laura Sepp-Lorenzino, Chief Officer — sold $19.6K of Intellia Therapeutics NTLA · 1.5% of holdings · 10b5-1 plan | Whalegun